MEDICINE DETAILS
Increlex
Active ingredient: Mecasermin
Official EMA and FDA records identify Increlex as a mecasermin solution for injection. The recorded vial contains 40 mg in 4 mL, equivalent to a concentration of 10 mg/mL.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Increlex used for?
INCRELEX (Mecasermin) is a prescription medicine used to treat children with severe growth failure due to primary IGF-1 deficiency. It provides insulin-like growth factor-1 (IGF-1) to support normal growth and development.
This condition can result in stunted growth and significantly impact a child’s height and overall development. INCRELEX works by replacing the missing IGF-1, helping bones and muscles grow properly, promoting height increase, and improving overall growth.
The medication is administered via daily subcutaneous (under-the-skin) injection and is prescribed only for children with confirmed IGF-1 deficiency. Treatment must be supervised by a doctor, and blood sugar levels should be monitored to prevent hypoglycemia (low blood sugar).
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Increlex identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
OFFICIAL RECORD SUMMARY
Product details checked against regulatory sources
Official EMA and FDA records identify Increlex as a mecasermin solution for injection. The recorded vial contains 40 mg in 4 mL, equivalent to a concentration of 10 mg/mL.
- ✓Solution for injection
- ✓40 mg/4 mL vial
- ✓Recorded concentration: 10 mg/mL
Presentations can differ by jurisdiction and authorisation. This list is not a use or dosing recommendation.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
10 mg/ml · 1 vial Catalogue organisation: IPSEN PHARMA GmbH
OFFICIAL SOURCES
Check the Increlex record at an official source.
Search for “Increlex” or “Mecasermin”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗ PRODUCT-SPECIFIC OFFICIAL RECORD EMA — Increlex EPAREuropean public assessment information for Increlex.
↗ PRODUCT-SPECIFIC OFFICIAL RECORD FDA — Increlex prescribing informationFDA-approved U.S. prescribing information and vial presentation.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Increlex.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Increlex
01What is Increlex?＋
This directory record associates the brand name Increlex with the active ingredient Mecasermin. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Increlex strengths and packs are recorded?＋
The catalogue currently shows: 10 mg/ml · 1 vial. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Increlex?＋
Catalogue records currently name: IPSEN PHARMA GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Increlex?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Increlex, payment request, stock guarantee or binding offer.
06Can I buy Increlex from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.